By Lucy Parkinson, Senior Research Manager, LSN
Here at LSN, we’re getting ready to go home for Thanksgiving. But first, we’d like to thank all our readers, supporters and friends across the global life science industry. We wouldn’t be here without you.
In the spirit of the season, LSN Research welcomes you to the table to share the mandates we’ve gathered from our recent conversations with investors across the world. This cornucopia of investors are from 6 different nations, and cover every niche of the life science sector – from agriculture to therapeutics to devices to healthcare IT.
Click on the mandates below to see what’s cooking in the rest of the world
- Private Equity Firm Seeks AgBio and Sustainable Bio Opportunities
- Early Stage VC Seeks Healthcare IT Opportunities
- Global Firm With Patient-Centric Strategy Invests In Oncology, Cardiovascular, Anti-infectives, CNS/pain, and Women’s Health
- Taiwan-based VC Investing In Innovative Early-Stage Medtech
- South American Corporate VC Interested in Orphan Drugs
- UK-based Fund Group Seeks Medical Devices, Diagnostics, Lab Equipment, and Healthcare IT
- Cross-Border VC Looking At Healthcare Technology for Emerging Markets
- Global Health Organization Funds Diagnostics, Vaccines and Women’s Health
- European PE Invests in Drug Development, Diagnostics, and Medical Devices
- Dutch Firm Investing In Medtech, Healthcare IT, and Biotech R&D Services
Next Phase Newsletter 
Leave a comment